Novartis AG (NVS) is a publicly traded Healthcare sector company. As of August 19, 2026, NVS trades at $160.15 with a market cap of $293.76B and a P/E ratio of 0.00. NVS moved +3.85% today. Year to date, NVS is +12.10%; over the trailing twelve months it is +24.63%. Its 52-week range spans $96.91 to $170.46. Analyst consensus is neutral with an average price target of $159.00. Rallies surfaces NVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Novartis AG (NVS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NVS moved +3.85% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $160.15 |
| Market Cap | $293.76B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 4.74% |
| 52-Week High | $170.46 |
| 52-Week Low | $96.91 |
| Volume | 2.28M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover NVS: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $159.00.